New automated assay of small dense low-density lipoprotein cholesterol identifies risk of coronary heart disease: the Multi-ethnic Study of Atherosclerosis
- PMID: 24233487
- PMCID: PMC4211254
- DOI: 10.1161/ATVBAHA.113.302401
New automated assay of small dense low-density lipoprotein cholesterol identifies risk of coronary heart disease: the Multi-ethnic Study of Atherosclerosis
Abstract
Objective: Coronary heart disease (CHD) is the leading cause of death in the United States, yet assessing risk of its development remains challenging. The present study evaluates a new automated assay of small dense low-density lipoprotein cholesterol content (sdLDL-C) and whether sdLDL-C is a risk factor for CHD compared with LDL-C or small LDL particle concentrations derived from nuclear magnetic resonance spectroscopy.
Approach and results: sdLDL-C was measured using a new automated enzymatic method, and small LDL concentrations were obtained by nuclear magnetic resonance in 4387 Multi-Ethnic Study of Atherosclerosis participants. Cox regression analysis estimated hazard ratios for developing CHD for 8.5 years after adjustments for age, race, sex, systolic blood pressure, hypertension medication use, high-density lipoprotein cholesterol, and triglycerides. Elevated sdLDL-C was a risk factor for CHD in normoglycemic individuals. Those in the top sdLDL-C quartile showed higher risk of incident CHD (hazard ratio, 2.41; P=0.0037) compared with those in the bottom quartile and indicated greater CHD risk than the corresponding quartile of LDL-C (hazard ratio, 1.75; P=0.019). The association of sdLDL-C with CHD risk remained significant when LDL-C (<2.57 mmol/L) was included in a multivariate model (hazard ratio, 2.37; P=0.012). Nuclear magnetic resonance-derived small LDL concentrations did not convey a significant risk of CHD. Those with impaired fasting glucose or diabetes mellitus showed higher sdLDL-C and small LDL concentrations but neither was associated with higher CHD risk in these individuals.
Conclusions: This new automated method for sdLDL-C identifies risk for CHD that would remain undetected using standard lipid measures, but only in normoglycemic, nondiabetic individuals.
Keywords: coronary disease.
Conflict of interest statement
M.Y. Tsai received consulting fees from the manufacturer of the small dense low-density lipoprotein cholesterol (sdLDL-C) assay (Denka Seiken). R. Warnick, D.M. Hoefner, and J. McConnell are associated with Health Diagnostic Laboratory, Inc, the clinical laboratory responsible for obtaining sdLDL-C data in the present study. J. McConnell serves as the chief medical officer, R. Warnick serves as the chief scientific officer, and D.M. Hoefner serves as the director of Technology and Development. The other authors report no conflicts.
Figures
Similar articles
-
Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study.Arterioscler Thromb Vasc Biol. 2014 May;34(5):1069-77. doi: 10.1161/ATVBAHA.114.303284. Epub 2014 Feb 20. Arterioscler Thromb Vasc Biol. 2014. PMID: 24558110 Free PMC article.
-
Association of small, dense LDL-cholesterol concentration and lipoprotein particle characteristics with coronary heart disease: A systematic review and meta-analysis.PLoS One. 2020 Nov 9;15(11):e0241993. doi: 10.1371/journal.pone.0241993. eCollection 2020. PLoS One. 2020. PMID: 33166340 Free PMC article.
-
Use of lipoprotein particle measures for assessing coronary heart disease risk post-American Heart Association/American College of Cardiology guidelines: the Multi-Ethnic Study of Atherosclerosis.Arterioscler Thromb Vasc Biol. 2015 Feb;35(2):448-54. doi: 10.1161/ATVBAHA.114.304349. Epub 2014 Dec 4. Arterioscler Thromb Vasc Biol. 2015. PMID: 25477346 Free PMC article.
-
Small Dense Low-Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study.J Am Heart Assoc. 2021 Feb;10(5):e019140. doi: 10.1161/JAHA.120.019140. Epub 2021 Feb 15. J Am Heart Assoc. 2021. PMID: 33586462 Free PMC article.
-
Clinical significance of small dense low-density lipoprotein cholesterol measurement in type 2 diabetes.J Diabetes Investig. 2025 Mar;16(3):370-383. doi: 10.1111/jdi.14398. Epub 2025 Jan 7. J Diabetes Investig. 2025. PMID: 39778086 Free PMC article. Review.
Cited by
-
Validation of Estimated Small Dense Low-Density Lipoprotein Cholesterol Concentration in a Japanese General Population.J Atheroscler Thromb. 2024 Jun 1;31(6):931-952. doi: 10.5551/jat.64578. Epub 2023 Dec 29. J Atheroscler Thromb. 2024. PMID: 38171805 Free PMC article.
-
Effects of dapagliflozin in the progression of atherosclerosis in patients with type 2 diabetes: a meta-analysis of randomized controlled trials.Diabetol Metab Syndr. 2022 Mar 10;14(1):41. doi: 10.1186/s13098-022-00810-3. Diabetol Metab Syndr. 2022. PMID: 35272683 Free PMC article. Review.
-
Small, Dense Low-Density Lipoprotein-Cholesterol and Atherosclerosis: Relationship and Therapeutic Strategies.Front Cardiovasc Med. 2022 Feb 10;8:804214. doi: 10.3389/fcvm.2021.804214. eCollection 2021. Front Cardiovasc Med. 2022. PMID: 35224026 Free PMC article. Review.
-
Small-Dense Low-Density Lipoprotein Cholesterol: A Subclinical Marker for the Primary Prevention of Coronary Heart Disease.J Atheroscler Thromb. 2020 Jul 1;27(7):641-643. doi: 10.5551/jat.ED134. Epub 2020 May 29. J Atheroscler Thromb. 2020. PMID: 32475866 Free PMC article. No abstract available.
-
Association of small dense low-density lipoprotein with cardiovascular outcome in patients with coronary artery disease and diabetes: a prospective, observational cohort study.Cardiovasc Diabetol. 2020 Apr 3;19(1):45. doi: 10.1186/s12933-020-01015-6. Cardiovasc Diabetol. 2020. PMID: 32245386 Free PMC article.
References
-
- Sachdeva A, Cannon CP, Deedwania PC, Labresh KA, Smith SC, Jr, Dai D, Hernandez A, Fonarow GC. Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines. Am Heart J. 2009;157:111–117. e2. - PubMed
-
- El Harchaoui K, van der Steeg WA, Stroes ES, Kuivenhoven JA, Otvos JD, Wareham NJ, Hutten BA, Kastelein JJ, Khaw KT, Boekholdt SM. Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study. J Am Coll Cardiol. 2007;49:547–553. - PubMed
-
- Kamigaki AS, Siscovick DS, Schwartz SM, Psaty BM, Edwards KL, Raghunathan TE, Austin MA. Low density lipoprotein particle size and risk of early-onset myocardial infarction in women. Am J Epidemiol. 2001;153:939–945. - PubMed
-
- Zeljkovic A, Vekic J, Spasojevic-Kalimanovska V, Jelic-Ivanovic Z, Bogavac-Stanojevic N, Gulan B, Spasic S. LDL and HDL subclasses in acute ischemic stroke: prediction of risk and short-term mortality. Atherosclerosis. 2010;210:548–554. - PubMed
-
- Blake GJ, Otvos JD, Rifai N, Ridker PM. Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women. Circulation. 2002;106:1930–1937. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- N01 HC095167/HC/NHLBI NIH HHS/United States
- N01 HC095169/HL/NHLBI NIH HHS/United States
- N01 HC095161/HC/NHLBI NIH HHS/United States
- N01 HC095164/HC/NHLBI NIH HHS/United States
- N01-HC-95159/HC/NHLBI NIH HHS/United States
- N01 HC095159/HL/NHLBI NIH HHS/United States
- N01-HC-95169/HC/NHLBI NIH HHS/United States
- N01 HC095169/HC/NHLBI NIH HHS/United States
- N01 HC095165/HC/NHLBI NIH HHS/United States
- N01 HC095168/HC/NHLBI NIH HHS/United States
- N01 HC095163/HC/NHLBI NIH HHS/United States
- N01 HC095162/HC/NHLBI NIH HHS/United States
- N01 HC095159/HC/NHLBI NIH HHS/United States
- N01 HC095166/HC/NHLBI NIH HHS/United States
- N01 HC095160/HC/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases